ITCI - Intracellular Th - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ITCI is currently covered by 13 analysts with an average price target of $137.77. This is a potential upside of $5.9 (4.47%) from yesterday's end of day stock price of $131.87.

Intracellular Th's activity chart (see below) currently has 150 price targets and 174 ratings on display. The stock rating distribution of ITCI is 82.28% BUY and 17.72% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.88% with an average time for these price targets to be met of 480.05 days.

Highest price target for ITCI is $132, Lowest price target is $74, average price target is $108.17.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 02-Apr-2025. First documented stock forecast 14-Apr-2015.

Currently out of the existing stock ratings of ITCI, 65 are a BUY (82.28%), 14 are a HOLD (17.72%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$132

$0.13 (0.10%)

$132

7 days ago
(02-Apr-2025)

28/30 (93.33%)

$0.13 (0.10%)

476

Buy

$132

$0.13 (0.10%)

$100

1 months 16 days ago
(24-Feb-2025)

10/11 (90.91%)

$3.46 (2.69%)

292

Hold

$100

1 months 19 days ago
(21-Feb-2025)

21/22 (95.45%)

$-27.19 (-21.38%)

170

Hold

$132

$0.13 (0.10%)

$113

2 months 9 days ago
(31-Jan-2025)

12/13 (92.31%)

$4.92 (3.87%)

738

Hold

$132

$0.13 (0.10%)

$108

2 months 18 days ago
(22-Jan-2025)

24/25 (96%)

$4.85 (3.81%)

233

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITCI (Intracellular Th) average time for price targets to be met?

On average it took 480.05 days on average for the stock forecasts to be realized with a an average price target met ratio 93.88

Which analyst has the current highest performing score on ITCI (Intracellular Th) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on ITCI (Intracellular Th)?

Sumant Kulkarni works at CANACCORD and has 9 price targets and 9 ratings on ITCI

Which analyst is the currently most bullish on ITCI (Intracellular Th)?

David Amsellem with highest potential upside - $0.13

Which analyst is the currently most reserved on ITCI (Intracellular Th)?

Edward Nash with lowest potential downside - -$103.87

Intracellular Th in the News

Why Mark Minervini may look into INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI)

Enable social media cookies to share Why Mark Minervini may look into INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI) By Mill Chart Last update: Apr 8, 2025 Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI) is suited for growth investing. Investors...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?